Remicade

Higher doses of Remicade (infliximab) can ease the symptoms of inflammatory bowel disease (IBD) by better controlling inflammation with raising the risk of adverse effects — like more infections — in ... Read more

Remicade (infliximab) significantly benefitted the mental health of patients newly diagnosed with Crohn’s disease who had responded to the treatment, improving their perceptions of their illness and quality of life, and lowering anxiety levels, ... Read more

Crohn’s disease management often requires the use of biologic medications. Premedication is used to help prevent adverse reactions from these treatments. To prepare for any medication, reducing medication reactions and the ... Read more

After Remicade (infliximab) and Humira (adalimumab) failed me — along with sulfasalazine, mesalamine, and budesonide — I started the biologic Entyvio (vedolizumab) last June as my main Crohn’s disease management medication. I still didn’t ... Read more

New drug Renflexis (infliximab-abda), a therapy for ulcerative colitis and Crohn’s disease, is being launched in the U.S., South Korea’s Samsung Bioepis recently announced. Renflexis is a biosimilar of the ... Read more

Miraca Life Sciences‘ InformTx testing helps doctors assess the response of patients with inflammatory bowel disease (IBD) to certain drug treatments. The company has now expanded its therapeutic drug ... Read more

IBD News Today

Disclaimer:

IBD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Pin It on Pinterest

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more